☰

Donna Paulnock, Ph.D. - Publications

Affiliations: 
Medical Microbiology and Immunology University of Wisconsin, Madison, Madison, WI 
Area:
Immunology, Parasitology
Website:
http://www.microbes.wisc.edu/symbiosis/faculty/paulnock.html
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Paulnock DM, Freeman BE, Mansfield JM. Modulation of innate immunity by African trypanosomes. Parasitology. 137: 2051-63. PMID 21087532 DOI: 10.1017/S0031182010001460  0.706
2009 Dagenais TR, Freeman BE, Demick KP, Paulnock DM, Mansfield JM. Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. Journal of Immunology (Baltimore, Md. : 1950). 183: 3344-55. PMID 19675169 DOI: 10.4049/Jimmunol.0802005  0.718
2009 Dagenais TR, Demick KP, Bangs JD, Forest KT, Paulnock DM, Mansfield JM. T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions. Infection and Immunity. 77: 141-51. PMID 18936180 DOI: 10.1128/Iai.00729-08  0.624
2008 Lopez R, Demick KP, Mansfield JM, Paulnock DM. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. Journal of Immunology (Baltimore, Md. : 1950). 181: 4908-17. PMID 18802094 DOI: 10.4049/Jimmunol.181.7.4908  0.655
2007 Leppert BJ, Mansfield JM, Paulnock DM. The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. Journal of Immunology (Baltimore, Md. : 1950). 179: 548-56. PMID 17579076 DOI: 10.4049/Jimmunol.179.1.548  0.687
2007 Harris TH, Mansfield JM, Paulnock DM. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infection and Immunity. 75: 2366-73. PMID 17339353 DOI: 10.1128/Iai.01649-06  0.677
2006 Harris TH, Cooney NM, Mansfield JM, Paulnock DM. Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infection and Immunity. 74: 4530-7. PMID 16861639 DOI: 10.1128/Iai.01938-05  0.667
2006 Lum HD, Buhtoiarov IN, Schmidt BE, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha. Immunology. 118: 261-70. PMID 16771862 DOI: 10.1111/J.1365-2567.2006.02366.X  0.397
2005 Mansfield JM, Paulnock DM. Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunology. 27: 361-71. PMID 16179030 DOI: 10.1111/j.1365-3024.2005.00791.x  0.379
2005 Buhtoiarov IN, Lum H, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro. Journal of Immunology (Baltimore, Md. : 1950). 174: 6013-22. PMID 15879094 DOI: 10.4049/Jimmunol.174.10.6013  0.375
2003 Coller SP, Mansfield JM, Paulnock DM. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. Journal of Immunology (Baltimore, Md. : 1950). 171: 1466-72. PMID 12874239 DOI: 10.4049/Jimmunol.171.3.1466  0.781
2001 Coller SP, Paulnock DM. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. Journal of Leukocyte Biology. 70: 142-8. PMID 11435497 DOI: 10.1189/Jlb.70.1.142  0.755
2001 Paulnock DM, Coller SP. Analysis of macrophage activation in African trypanosomiasis. Journal of Leukocyte Biology. 69: 685-90. PMID 11358974 DOI: 10.1189/Jlb.69.5.685  0.774
2000 Paulnock DM, Demick KP, Coller SP. Analysis of interferon-gamma-dependent and -independent pathways of macrophage activation. Journal of Leukocyte Biology. 67: 677-82. PMID 10811008 DOI: 10.1002/Jlb.67.5.677  0.78
1998 Lokuta MA, McDowell MA, Paulnock DM. Identification of an additional isoform of STAT5 expressed in immature macrophages. Journal of Immunology (Baltimore, Md. : 1950). 161: 1594-7. PMID 9712020  0.586
1998 Lucas DM, Lokuta MA, McDowell MA, Doan JE, Paulnock DM. Analysis of the IFN-gamma-signaling pathway in macrophages at different stages of maturation. Journal of Immunology (Baltimore, Md. : 1950). 160: 4337-42. PMID 9574537  0.691
1995 McDowell MA, Lucas DM, Nicolet CM, Paulnock DM. Differential utilization of IFN-gamma-responsive elements in two maturationally distinct macrophage cell lines. Journal of Immunology (Baltimore, Md. : 1950). 155: 4933-8. PMID 7594498  0.65
1994 Nicolet CM, Paulnock DM. Promoter analysis of an interferon-inducible gene associated with macrophage activation. Journal of Immunology (Baltimore, Md. : 1950). 152: 153-62. PMID 8254188  0.4
1994 Paulnock DM. The molecular biology of macrophage activation. Immunology Series. 60: 47-62. PMID 8251587  0.345
1992 Paulnock DM. Macrophage activation by T cells. Current Opinion in Immunology. 4: 344-9. PMID 1418715 DOI: 10.1016/0952-7915(92)90087-U  0.415
1992 Wynn TA, Freund YR, Paulnock DM. TNF-alpha differentially regulates Ia antigen expression and macrophage tumoricidal activity in two murine macrophage cell lines. Cellular Immunology. 140: 184-96. PMID 1310901 DOI: 10.1016/0008-8749(92)90186-S  0.45
1991 Wynn TA, Nicolet CM, Paulnock DM. Identification and characterization of a new gene family induced during macrophage activation. Journal of Immunology (Baltimore, Md. : 1950). 147: 4384-92. PMID 1753106  0.389
1990 Haak-Frendscho M, Wynn TA, Czuprynski CJ, Paulnock D. Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing. Clinical and Experimental Immunology. 82: 404-10. PMID 2242621 DOI: 10.1111/J.1365-2249.1990.Tb05461.X  0.386
1990 Paulnock DM, Lambert LE. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. Journal of Immunology (Baltimore, Md. : 1950). 144: 765-73. PMID 2104906  0.49
1989 Lambert LE, Paulnock DM. Differential induction of activation markers in macrophage cell lines by interferon-gamma. Cellular Immunology. 120: 401-18. PMID 2541931 DOI: 10.1016/0008-8749(89)90208-6  0.504
1989 Guagliardi LE, Byrne GI, Paulnock DM. Differential modulation of lymphocyte proliferative responses and lymphokine secretion in mice during development of immunity to Chlamydia psittaci. Infection and Immunity. 57: 1561-7. PMID 2496033 DOI: 10.1128/Iai.57.5.1561-1567.1989  0.352
1988 Byrne GI, Guagliardi LE, Huebner RE, Paulnock DM. Immunomodulation and Chlamydia: immunosuppression and the protective immune response to C. psittaci in mice. Advances in Experimental Medicine and Biology. 239: 343-52. PMID 3059773 DOI: 10.1007/978-1-4757-5421-6_33  0.301
1988 Spear GT, Paulnock DM, Helgeson DO, Borden EC. Requirement of differentiative signals of both interferon-gamma and 1,25-dihydroxyvitamin D3 for induction and secretion of interleukin-1 by HL-60 cells. Cancer Research. 48: 1740-4. PMID 2832052  0.343
1987 Lambert LE, Paulnock DM. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway. Journal of Immunology (Baltimore, Md. : 1950). 139: 2834-41. PMID 3116096  0.498
Show low-probability matches.